Dental Bone Graft Substitute Market Worth $659 million by 2025 - Growing Demand From Emerging Markets

 

Growth in the dental bone graft substitute market is driven primarily by the increasing prevalence of dental disorders, continuous product commercialization, market availability & product affordability, rising number of geriatric population, and growing public awareness related to preventive care are driving the growth of the dental bone graft substitute market.

According to the Latest Research by MarketsandMarkets “The global dental bone graft substitute market size is projected to reach USD 659 million by 2025 from USD 450 million in 2020, at a CAGR of 7.9% during the forecast period.”

Market Growth Opportunities:

1. Increasing demand from customers and rising inclination toward cosmetic dentistry
2. Low penetration rates for dental implants
3. Growing demand for bone graft substitutes from emerging markets
4. Changing demographics

Market Size Estimation:

The study involved four major activities to estimate the current size of the dental bone graft substitute market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments.

Both top-down and bottom-up approaches were used to estimate and validate the total size of the dental bone graft substitute market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

1. The key players in the industry and markets have been identified through extensive secondary research.

2. The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research.

3. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159678690

By type, synthetic bone graft segment is expected to grow at the highest CAGR during the forecast period

Increasing technological advancements have increased the number of synthetic graft options. The benefits of synthetic grafts include availability, sterility, and reduced morbidity. Also, the synthetic bone grafts have a longer shelf life and there is no risk of any disease to get transferred. Because of these benefits synthetic bone graft is the fastest growing type in the dental bone graft substitutes market.

The synthetic bone graft segment is expected to account for the 22.0% share of the global dental bone graft substitutes market in 2019. IngeniOs from Zimmer Biomet Holdings, Inc. (US) and MASTERGRAFT from BioHorizons IPH, Inc. (US) are some commonly used synthetic bone grafts.

Europe is the largest regional market for Dental bone graft substitute

Europe is one of the major revenue-generating regions in the dental bone graft substitute market. The favorable reimbursement & insurance coverage for major procedures and supportive government regulations for product commercialization are the major factors driving the growth of the dental bone graft substitute market in Europe.

Recent Developments:

1. In 2019, Straumann and Modern Dental Group Limited (Hong Kong) entered a joint venture to create distribution company that will serve the dental communities in Hong Kong and Macau; Peak Dental Solutions Hong Kong Ltd

2. In 2018, Dentsply acquired OraMetrix, a leading industry provider of innovative 3-D technology solutions improving the quality and efficiency of orthodontic care.

3. In 2018, Straumann acquired 30% stake in Botiss biomaterials.

4. In 2017, Straumann acquired 70% stake of its distributor Batigroup for taking over direct distribution of its products in Turkey.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=159678690

Key Players:

Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US), Medtronic (Ireland), Strauman (US), Zimmer Dental (US), Geistlich Pharm (Switzerland), RTI Surgical (US), BioHorizons, IPH, Inc (US), Dentium (South Korea), LifeSciences Corporation (US), Smith & Nephew (UK), Novabone LLC (US), Botiss biomaterials GmbH (US), Collagen Matrix Inc. (US), Osteogenics Biomedical (US), LifeNet Health (US), Wright Medical (US), and Stryker Corporation (US).

Danaher is one of the leaders in designing, manufacturing, and marketing innovative products and services to professional, medical, industrial, and commercial customers. The company holds a significant share in the global dental bone graft substitute market. To maintain its market position and ensure future growth, the company adopts organic and inorganic growth strategies.